OCWP
MRNA icon

Owl Creek Wealth Partners’s Moderna MRNA Stock Holding History

Owl Creek Wealth Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.3K Buy
576
+25
+5% +$1.29K 0.01% 426
2026
Q1 		$28K Buy
+551
New +$25.7K 0.01% 480

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Owl Creek Wealth Partners's MRNA Position: Q2 2026 in Review

Owl Creek Wealth Partners increased its Moderna (MRNA) stake by 4.5% in Q2 2026, buying an estimated $1.29K and bringing the position to 576 shares worth $40.3K. The position accounts for 0.01% of the portfolio, ranked #426.

Owl Creek Wealth Partners first reported a position in MRNA in Q1 2026 and has held it in 2 quarters since. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Owl Creek Wealth Partners held 576 shares of Moderna worth $40.3K as of Q2 2026.
  • Owl Creek Wealth Partners bought 25 Moderna shares in Q2 2026, an estimated $1.29K.
  • Moderna made up 0.01% of Owl Creek Wealth Partners's portfolio in Q2 2026, its #426 holding.
  • Owl Creek Wealth Partners first reported a position in Moderna in Q1 2026 and has held it in 2 quarters since.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Owl Creek Wealth Partners's 13F filing for Q2 2026, filed 20 Jul 2026.